AI assistant
Flyr AS — Capital/Financing Update 2022
May 5, 2022
3601_iss_2022-05-05_8aa9c76f-b068-40a2-bf4b-8d0ccca1b036.html
Capital/Financing Update
Open in viewerOpens in your device viewer
Flyr AS: Private Placement Successfully Placed
Flyr AS: Private Placement Successfully Placed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES
OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION
WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE
SECURITIES DESCRIBED HEREIN.
Reference is made to the stock exchange release from Flyr AS ("Flyr" or the
"Company") published on 5 May 2022 regarding a contemplated private placement.
The Company is pleased to announce that it has raised NOK 250 million in gross
proceeds through a private placement (the "Private Placement") of 208,333,333
new shares (the "New Shares"), at a price per share of NOK 1.20. The Private
Placement was carried out on the basis of an accelerated bookbuilding process
managed by Arctic Securities AS and Carnegie AS as joint bookrunners (the
"Managers") after close of markets on 5 May 2022.
The net proceeds from the Private Placement will be used to re-establish the
Company's financial position, fund expanding flight operations after the re
-opening, and general corporate purposes.
The Private Placement is divided into two tranches. The first tranche consists
of 29,787,349 New Shares ("Tranche 1") which is tradeable on Euronext Growth
Oslo upon receipt of notifications of allocation, expected to be on 6 May 2022.
The New Shares in Tranche 1 will be settled on a delivery versus payment basis
by delivery of existing and unencumbered shares listed on Euronext Growth Oslo
pursuant to a share lending agreement between the Company, the Managers and
Ojada AS . The share loan will be settled with new shares resolved issued by the
board of directors of the Company pursuant to an authorization granted by the
Company's extraordinary general meeting held on 4 January 2022. The share
capital increase pertaining to Tranche 1 is expected to be registered in the
NRBE on or about 11 May 2022.
The second tranche consists of 178,545,984 New Shares ("Tranche 2"). The issue
of the New Shares in Tranche 2 is subject to approval of the Company's
extraordinary general meeting expected to be held on or about 13 May 2022 (the
"EGM"). The New Shares conditionally allocated to investors in Tranche 2 will be
tradeable on Euronext Growth Oslo following a stock exchange announcement by the
Company announcing the registration of the share capital increase pertaining to
the New Shares in Tranche 2 in the Norwegian Register of Business Enterprises
("NRBE") on or about 16 May 2022. Settlement of the New Shares in Tranche 2 will
be on a delivery versus payment basis pursuant to a pre-payment agreement
between the Company and the Managers.
New Shares have been allocated among applicants on a pro-rata basis based on
their overall allocation in the Private Placement, except for Ojada AS who have
agreed to take delivery of their full allocation in Tranche 2.
Notification of allocation of New Shares in Tranche 1 and conditional allocation
of New Shares in Tranche 2 is expected to be distributed to investors on 6 May
Completion of Tranche 2 is subject to (i) the EGM resolving to issue the New
Shares in Tranche 2 and (ii) the registration of the share capital increase
pertaining to the New Shares in Tranche 2 with the NRBE and registration in the
VPS. Completion of Tranche 1 will not be conditional upon the completion of
Tranche 2. Investors that are allocated shares in the Private Placement
undertake to vote in favour of Tranche 2 at the EGM.
Following registration of the new share capital pertaining to Tranche 1 of the
Private Placement, the Company will have a share capital of NOK 908,947.366
divided into 454,473,683 shares, each with a par value of NOK 0.002. Following
registration of the new share capital pertaining to Tranche 2 of the Private
Placement, and subject to fulfilment of the conditions for Tranche 2, the
Company will have a share capital of NOK 1,266,039.334 divided into 633,019,667
shares, each with a par value of NOK 0.002.
Completion of the Private Placement implies a deviation from the pre-emptive
rights of the existing shareholders of the Company under the Norwegian Private
Limited Companies Act. When resolving the issuance of the New Shares in the
Private Placement, the Board considered this deviation and also the equal
treatment obligations under the Norwegian Securities Trading Act, the rules on
equal treatment under Oslo Rule Book II for companies listed on the Oslo Stock
Exchange and the Oslo Stock Exchange's Guidelines on the rule of equal
treatment. The Board is of the opinion that there are sufficient grounds to
deviate from the pre-emptive rights and that the Private Placement is in
compliance with the equal treatment requirements, in particular in view of the
current market conditions. By structuring the transaction as a private
placement, the Company was able to raise capital in an efficient manner with
significantly lower completion risks compared to a rights issue and strengthen
the Company's shareholder base. When reaching this conclusion, the Board also
emphasized that it intends to carry out the Subsequent Offering, as further
described below.
Subject to, inter alia, completion of the Private Placement, approval by the EGM
and the prevailing market price of the Company's shares, Flyr will carry out a
subsequent offering (the "Subsequent Offering") of up to 62,500,000 new shares
in the Company. The Subsequent Offering will, if made, be directed towards
existing shareholders in the Company as of 5 May 2022 (as registered with the
VPS two trading days thereafter) who (i) were not allocated New Shares in the
Private Placement, and (ii) are not resident in a jurisdiction where such
offering would be unlawful, or would (in jurisdictions other than Norway)
require any prospectus filing, registration or similar action (the "Eligible
Shareholders"). The Eligible Shareholders are expected to be granted non
-tradeable subscription rights. The subscription price in the Subsequent
Offering will be the same as in the Private Placement. The Company reserves the
right, at its sole discretion, to not conduct or to cancel the Subsequent
Offering.
The following persons discharging managerial responsibilities and close
associates have been allocated New Shares in the Private Placement, which is
regarded as PDMR/PCA trades under the Market Abuse Regulation (EU) No 596/2014:
- Erik G. Braathen was allocated 12,500,000 shares via Ojada AS
Detailed information on the PDMR/PCA trade will be disclosed separately.
Advisors
Arctic Securities AS and Carnegie AS act as Joint Bookrunners in the Private
Placement.
For further information, please contact:
Brede Huser, Chief Financial Officer
Phone: +47 99 16 99 74
Email: [email protected]
About Flyr
Flyr is a Norwegian based low-cost carrier with a demand driven business model
and a primary focus on the Norwegian market. The company targets a modern,
digital, and efficient setup to ensure high operational efficiency through
simplicity, optimized resource utilization and smart use of technology. Flyr AS
is listed at Euronext Growth under the ticker FLYR.
This information is considered to be inside information pursuant to the EU
Market Abuse Regulation. This stock exchange release was published by Brede
Huser, Chief Financial Officer on the time and date provided.
Important information
The release is not for publication or distribution, in whole or in part directly
or indirectly, in or into Australia, Canada, Japan Hong Kong or the United
States (including its territories and possessions, any state of the United
States and the District of Columbia). This release is an announcement issued
pursuant to legal information obligations and is subject to the disclosure
requirements of section 5-12 of the Norwegian Securities Trading Act. It is
issued for information purposes only and does not constitute or form part of any
offer or solicitation to purchase or subscribe for securities, in the United
States or in any other jurisdiction. The securities mentioned herein have not
been, and will not be, registered under the United States Securities Act of
1933, as amended (the "US Securities Act"). The securities may not be offered or
sold in the United States except pursuant to an exemption from the registration
requirements of the US Securities Act. The Company does not intend to register
any portion of any offering of the securities in the United States or to conduct
a public offering of the securities in the United States. Copies of this
announcement are not being made and may not be distributed or sent into
Australia, Canada, Japan or the United States.
The issue, subscription or purchase of shares in the Company is subject to
specific legal or regulatory restrictions in certain jurisdictions. Neither the
Company nor the Managers assume any responsibility in the event there is a
violation by any person of such restrictions. The distribution of this release
may in certain jurisdictions be restricted by law. Persons into whose possession
this release comes should inform themselves about and observe any such
restrictions. Any failure to comply with these restrictions may constitute a
violation of the securities laws of any such jurisdiction.
The Managers are acting for the Company and no one else in connection with the
potential Private Placement in the Company, and will not be responsible to
anyone other than the Company providing the protections afforded to their
respective clients or for providing advice in relation to the Private Placement
and/or any other matter referred to in this release.
Forward-looking statements: This release and any materials distributed in
connection with this release may contain certain forward-looking statements. By
their nature, forward-looking statements involve risk and uncertainty because
they reflect the Company's current expectations and assumptions as to future
events and circumstances that may not prove accurate. A number of material
factors could cause actual results and developments to differ materially from
those expressed or implied by these forward-looking statements.